Advancements in clinical data and research have shown the immunotherapeutic potential of bispecific antibodies as treatment for hematologic cancers and solid tumors. In this episode, CANCER BUZZ speaks with Aaron Cumpston, PharmD, pharmacy clinical specialist for bone marrow transplant and Christine Barrett, PharmD, BCOP, medical oncology clinical pharmacy specialist who discuss the challenges of care coordination and therapy and share operational best practices for the delivery of bispecific antibodies in the community setting.
“I think we’re finding these drugs to be highly effective and having high response rates and also very durable response rates in very refractory patients.”—Aaron Cumpston, PharmD, BCOP
“I know that in community practice it can be really difficult, but there is a network of institutions out there that have taken on administering these BiTE therapies and have a lot of experience that can be very helpful for those in community practice.” —Christine Barrett, PharmD, BCOP
Aaron Cumpston, PharmD, BCOP
Pharmacy Clinical Specialist – Hematologic Malignancy, Transplant, and Cellular Therapy
WVU Medicine
WVU Cancer Institute - Mary Babb Randolph Cancer Center
Morgantown, WV
Christine Barrett, PharmD, BCOP
Medical Oncology Clinical Pharmacy Specialist
WVU Medicine
WVU Cancer Institute - Mary Babb Randolph Cancer Center
Morgantown, WV
This episode was developed in connection with the ACCC education program Sharing Operational Insights for the Delivery of Bispecific Antibodies in Solid Tumor and is supported by Amgen.
Resources:
Expanding Access to Cellular and Bispecific Therapies – Considerations and Recommendations by ACCC and SITC
Sharing Operational Insights for the Delivery of Bispecific Antibodies in Solid Tumor
Best Practices in Expanding Access to Bispecific Antibodies and Adverse Event Management
Integrating Genetic Counselors in Routine Genitourinary Care
A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML
Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer
Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education
Care Action Plans for People with Cancer
Beyond the Brush: Navigating Dental Care in Head & Neck Cancer
Policy Perspectives on Biomarker Testing Coverage for 2024
Open Enrollment: Best Practices for End-of-Year Prep
Disparities in Accessing Care for AML Patients: Challenges and Solutions
Clarifying the Role of Maintenance Therapy
A Conversation With ACCC’s Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit
LIVE from AMCCBS: White House Update
LIVE from AMCCBS: Capitol Hill Update
LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services
LIVE from AMCCBS: New Payments for Patient Navigation
LIVE from AMCCBS: Financial Advocacy Resources
Making the Case for Head & Neck Cancer Patient Care Navigators
The Florez Lab: Increasing Retention and Improving Productivity of Under-Represented in Medicine Trainees
BRCA Testing Survey Insights: A Multidisciplinary Perspective on Testing and Treatment for Patients with Breast Cancer
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain